Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 3, 2011BloodOpen Access

The Myeloproliferative Neoplasm Symptom Assessment Form (MPN-SAF): International Prospective Validation and Reliability Trial in 402 patients

View Full Paper
Ask AI
Bookmark
Share

Authors

RSRobyn M. ScherberThe University of Texas Health Science Center at San AntonioADAmylou C. DueckScottsdale Community CollegePJPeter JohanssonLinköping University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Scherber et al. (2011) studied this question.

synapsesocial.com/papers/6a0f94965725bbd5cc5fe091https://doi.org/10.1182/blood-2011-01-328955
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The burden of fatigue and quality of life in myeloproliferative disorders (MPDs)2006 · 402 citations
  2. 2New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment2008 · 1,259 citations
  3. 3Safety and Efficacy of INCB018424, a JAK1 and JAK2 Inhibitor, in Myelofibrosis2010 · 1,172 citations
  4. 4The rapid assessment of fatigue severity in cancer patients1999 · 1,804 citations
  5. 5The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology1993 · 16,271 citations